2nd subcommittee on children: Expert reviews
-
Acetylcysteine (Review) -- Reviewer 1
pdf, 119kb -
Acetylcysteine (Review) -- Reviewer 2
pdf, 19kb -
Antiemetic medicines (Review) -- Reviewer 1
pdf, 95kb -
Carbapenems (Review) -- Reviewer 1
pdf, 103kb -
Cefalexin (Inclusion) -- Reviewer 1
pdf, 206kb -
Cefalexin (Inclusion) -- Reviewer 2
pdf, 45kb -
Ceftazidime (Review) -- Reviewer 1
pdf, 94kb -
Ceftazidime (Review) -- Reviewer 2
pdf, 102kb -
Ceftriaxone (New formulation) -- Reviewer 1
pdf, 113kb -
Ceftriaxone (New formulation) -- Reviewer 2
pdf, 111kb -
Charcoal, activated (Review) -- Reviewer 1
pdf, 129kb -
Charcoal, activated (Review) -- Reviewer 2
pdf, 125kb -
Chlorhexidine (New formulation) -- Reviewer 1
pdf, 106kb -
Chlorhexidine (New formulation) -- Reviewer 2
pdf, 93kb -
Cytotoxic medicines (Review) -- Reviewer 1
pdf, 182kb -
Cytotoxic medicines (Review) -- Reviewer 2
pdf, 125kb -
Dermatological medicines (Review) -- Reviewer 1
pdf, 26kb -
Dermatological medicines (Review) -- Reviewer 2
pdf, 69kb -
ENT (New section) -- Reviewer 1
pdf, 50kb -
ENT (New section) -- Reviewer 2
pdf, 109kb -
Fluoroquinolones (Review) -- Reviewer 1
pdf, 94kb -
Fluoroquinolones (Review) -- Reviewer 2
pdf, 100kb -
Gentamicin (Review) -- Reviewer 1
pdf, 104kb -
Gentamicin (Review) -- Reviewer 2
pdf, 109kb -
Hydrocortisone and fludrocortisone (Inclusion) -- Reviewer 1
pdf, 123kb -
Hydrocortisone and fludrocortisone (Inclusion) -- Reviewer 2
pdf, 117kb -
Lamivudine, nevirapine, zidovudine (New form) -- Reviewer 1
pdf, 246kb -
LNZ (New formulation) -- Reviewer 2
pdf, 108kb -
Lamivudine, stavudine, nevirapine (New form) -- Reviewer 1
pdf, 242kb -
LSN (New formulation) -- Reviewer 2
pdf, 109kb -
Lamivudine, zidovudine (New formulation) -- Reviewer 1
pdf, 211kb -
LZ (New formulation) -- Reviewer 2
pdf, 108kb -
Liposomal amphotericin B (Inclusion) -- Reviewer 1
pdf, 106kb -
Liposomal amphotericin B (Inclusion) -- Reviewer 2
pdf, 99kb -
Macrolides (Review) -- Reviewer 1
pdf, 123kb -
Macrolides (Review) -- Reviewer 2
pdf, 139kb -
Medicines used in palliative care (Inclusion) -- Reviewer 1 (NEW)
pdf, 131kb -
Medicines used in palliative care (Inclusion) -- Reviewer 2
pdf, 56kb -
Methotrexate (Review) -- Reviewer 1 (NEW)
pdf, 108kb -
Methotrexate (Review) -- Reviewer 2
pdf, 106kb -
Neonates (Inclusion of a new section) -- Reviewer 1
pdf, 105kb -
Neonates (Inclusion of a new section) -- Reviewer 2
pdf, 147kb -
Pancreatic enzymes (Inclusion) -- Reviewer 1
pdf, 112kb -
Pancreatic enzymes (Inclusion) -- Reviewer 2
pdf, 108kb -
Pralidoxime (Inclusion) -- Reviewer 1
pdf, 98kb -
Pralidoxime (Inclusion) -- Reviewer 2
pdf, 111kb -
Procaine benzylpenicillin (Review) -- Reviewer 1
pdf, 114kb -
Procaine benzylpenicillin (Review) -- Reviewer 2
pdf, 115kb -
Psychotherapeutic medicines (Review) -- Reviewer 1
pdf, 53kb -
Psychotherapeutic medicines (Review) -- Reviewer 2
pdf, 122kb -
Quinidine (Review) -- Reviewer 1
pdf, 104kb -
Quinidine (Review) -- Reviewer 2
pdf, 109kb -
Retinol (Vitamin A) (Deletion of formulation) -- Reviewer 1
pdf, 117kb -
Retinol (Vitamin A) (Deletion of formulation) -- Reviewer 2 (NEW)
pdf, 106kb -
Salbutamol (Review) -- Reviewer 1
pdf, 111kb -
Salbutamol (Review) -- Reviewer 2
pdf, 261kb -
Sulfadiazine (Review) -- Reviewer 1
pdf, 115kb -
Sulfadiazine (Review) -- Reviewer 2
pdf, 113kb -
Surfactant (Inclusion) -- Reviewer 1
pdf, 118kb -
Surfactant (Inclusion) -- Reviewer 2
pdf, 139kb -
Tetracycline (Review) -- Reviewer 1
pdf, 113kb
Contact: emlsecretariat@who.int
Medicine Access and Rational Use (MAR)
20 Avenue Appia
CH-1211 Geneva 27